Learning how to use a new test can be overwhelming, especially when it goes back to neurology which you might not have thought of since medical school.
To assist health care providers in approaching neurotransmitter testing as a functional assessment, ZRT has outlined a series of key concepts below.
As with any functional test that measures physiological function, the challenge lies in the interpretation of subclinical levels of measured parameters. However, it is within those subclinical levels that the neurotransmitter test becomes a powerful tool to identify what is contributing to a specific patient's health issues and how to map toward a successful outcome based on an individual treatment plan.
Before looking at specific neurotransmitters, let's review some important fundamentals needed for neurotransmitter interpretation.
- Patterns are just as important as numbers
It is important to look at the relative levels of neurotransmitters and their relationships with one another. Patterns are just as important, if not more important, as the numbers themselves. For example, a low serotonin with a high 5HIAA can suggest sluggish MAO A activity; GABA and glutamate should balance each other; and serotonin and dopamine should both increase or decrease together.
- Treatment considerations for generally low levels of neurotransmitters
With generally low-normal or low neurotransmitter results, treatment considerations include, but are not limited to, precursor amino acid supplementation and cofactor support such as B vitamins, magnesium, zinc, vitamin C, and folate.
- Treatment considerations for generally elevated levels of neurotransmitters
Treatment strategies should focus on reducing potentially neurotoxic excitatory damage with anti-oxidants, anti-inflammatory support, and neuroprotective therapies. These include: omega 3 fatty acids, glutathione, and N-acetyl cysteine.
- Devising the treatment plan
Address inhibitory neurotransmitter support first (for example – 5HTP, GABA) and then excitatory support (for example – tyrosine, glutamine), otherwise undesirable side effects such as anxiety and agitation may arise. It is typically safe to introduce excitatory support after approximately a week of inhibitory support.
Now, let’s look at some common patterns that we see in neurotransmitter testing and review some facts that are pertinent when interpreting results.
- Low serotonin with SSRI therapy
Low urinary serotonin levels are not uncommon in patients on prolonged SSRI use. Over time, SSRIs deplete serotonin from platelets , which could be reflected in the low urinary serotonin result. This is commonly why SSRI treatments will require increasing dosages or stop working over time.
- Unexpectedly high serotonin levels
High serotonin in urine could result from many conditions including, but not limited to, food allergies, post infectious IBS, low vitamin D levels, and use of medications or supplements geared to boost serotonin, such as 5HTP. Fun fact: the GI tract makes a lot of serotonin when GI inflammation is triggered .
- PEA is the only neurotransmitter that crosses the blood brain barrier freely and bidirectionally
Low PEA in urine serves as a recognized biomarker in ADHD . ADHD patients that respond well to treatment typically show marked increases in urinary PEA levels. On the flip side, high PEA (it can be very high) is associated with anxiety. High PEA can be addressed by supplementing with SAMe, vitamin B2, copper with zinc, or nutritional lithium.
- GABA does not need to cross the blood brain barrier to exert calming effects
The literature has been inconsistent regarding whether or not GABA crosses the blood brain barrier when taken as a supplement. However, since GABA taken as a supplement can be very effective in relieving symptoms of anxiety for a sizeable cohort of patients, this begs the question of its mechanism of action. Recent studies from animals begin to shed light into peripheral mechanisms of GABA action. Specifically, within the adrenal glands, GABA regulates epinephrine (and a small amount of norepinephrine) release to make sure the anxiety-provoking “fight or flight” response is not overdone . That could certainly serve as one of the calming mechanisms of GABA action in the periphery. Therefore, when interpreting a neurotransmitter report, determining the relationship between GABA levels and norepinephrine/epinephrine levels is important. With low GABA, it may be that much more challenging to bring down the sympathetic/adrenal overdrive.
- Urinary norepinephrine is a product of the sympathetic nervous system
Most urinary norepinephrine originates from the sympathetic nerve endings, giving us an idea of how the peripheral nerves are firing. Because of the involvement of the nervous system, abnormal norepinephrine results could be addressed by introducing herbal nervines (e.g., Melissa officinalis, Passiflora officinalis) and biofeedback in the treatment protocol.
- Epinephrine is adrenal in origin
Urinary epinephrine measured by the test, on the other hand, is mostly adrenal in origin, therefore treatment typically involves adrenal adaptogens and lifestyle interventions to reduce stress.
- Utility of a diurnal norepinephrine and epinephrine assessment
Sometimes when patients report being under a lot of stress and self-report moderate to severe anxiety, sleep disturbances, and irritability, dysfunctions in the HPA axis and/or sympathetic nervous system may be suspected. However, their average urinary norepinephrine and epinephrine levels fall within the normal range. This seeming discrepancy in symptoms and test results could be addressed by running a distribution pattern at 4 time points during the day to see if these catecholamines are following a normal diurnal rhythm. Being able to determine alterations from a normal predictable circadian pattern could help the practitioner establish a better-tailored treatment plan, supporting when levels are low and suppressing when levels are high.
It takes experience and really knowing and integrating the subjective and objective aspects of a case to achieve a successful interpretation of the results. Learning to “speak the language” is the first step in incorporating the neurotransmitter test into everyday practice. As with any language, the initial building blocks are key to becoming fluent. Until then, we are here to help you as always. Feel free to call ZRT's clinicians for provider-to-provider consultation at 1-866-600-1636.
- Download: Neurotransmitter Provider Overview
- Download: Neurotranmitter Sample Report
- Blog: Diurnal Fluctuations in Norepinephrine & Epinephrine Levels as Part of the Healthy Stress Response
 Siesser WB, Sachs BD, Ramsey AJ, Sotnikova TD, Beaulieu JM, Zhang X, Caron MG, Gainetdinov RR: Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice. ACS Chem Neurosci 2013;4:84-88.
 Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-811.
 Irsfeld M, Spadafore M, Pruss BM: beta-phenylethylamine, a small molecule with a large impact. Webmedcentral 2013;4:9.
 Harada K, Matsuoka H, Fujihara H, Ueta Y, Yanagawa Y, Inoue M: GABA Signaling and Neuroactive Steroids in Adrenal Medullary Chromaffin Cells. Front Cell Neurosci 2016;10:100